← Leaderboards
William G Pitt
Brigham Young University
$1,917,929
Attributed
$6,259,239
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,259,239 · 3
By mechanism
R01$6,259,239 · 3
Top collaborators
- Aaron R. Hawkins5 shared
- Richard A Robison5 shared
- Holger Schmidt5 shared
- Adam Thomas Woolley5 shared
Most similar at Brigham Young University
Same institution · by research overlap
- Adam Thomas Woolley$5,211,274
- Richard A Robison$1,085,328
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsDevicesBacterial InfectionsCytolysisDetectionAntimicrobialDiagnosisBacterial ResistanceAntibiotic ResistanceComplexDesignBloodBlood CirculationBlood FiltrationDiagnostic AssayBlood SpecimenCarbapenemaseCarbapenem-Resistant EnterobacteriaceaeBaseCellsCessation Of LifeBacteremiaBacteriaDiagnostic Procedure
Grant awards (9)
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$982,407
R01 · FY2019 · AI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$988,510
R01 · FY2018 · AI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,002,828
R01 · FY2017 · AI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,069,803
R01 · FY2016 · AI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,383,090
R01 · FY2015 · AI
Controlled Drug Delivery to Colon Tumors Via Ultrasound$230,699
R01 · FY2006 · CA · contact PI
Controlled Drug Delivery to Colon Tumors Via Ultrasound$236,250
R01 · FY2005 · CA
Controlled Drug Delivery to Colon Tumors Via Ultrasound$246,000
R01 · FY2004 · CA
ULTRASONIC/ANTIBIOTIC THERAPY--INFECTED IMPLANT IN VIVO$119,652
R01 · FY2000 · HL